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a b s t r a c t 
Interleukin (IL)-4 is a critical stimulator that induces ε germline transcripts ( ε GT) for switch recombi-
nation to initiate immunoglobulin (Ig) E and is important in allergic disease pathogenesis. We found
pentagalloylglucose (PGG) inhibited IL-4-induced ε GT expression. PGG exerted its inhibitory function
by suppressing IL-4-induced activation of IL-4R α, JAK3 and STAT6. Furthermore, tannic acid, a higher
galloylated PGG, attenuated ovalbumin-induced IgE production in vivo by inhibiting IL-4-induced ε GT
expression and the IL-4 signaling pathway. In conclusion, our results suggest that tannic acid may
attenuate allergic diseases by suppressing IgE production by inhibiting IL-4-induced signaling. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. Open access under CC BY-NC-ND license. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
The incidence of allergic disease has increased dramatically re-
cently and in many countries, the prevalence has reached almost epi-
demic proportions [ 1 ]. Currently, a cure for these diseases does not
exist although a wide range of treatments is used to control symp-
toms. Thus, allergies have become a major medical and social issue
worldwide [ 2 ]. 
Interleukin (IL)-4 is thought to be a key cytokine in the early stages
of allergic diseases because of its important role in regulating B-cell
isotype switching to immunoglobulin (Ig) E production [ 3 , 4 ]. Its ef-
fects are mediated by a cell surface receptor unit, the IL-4 receptor
α-chain (IL-4R α) and the common γ-chain ( γc). At the intracellular
level, IL-4 activates the ε germline promoter that leads to the expres-
sion of ε germline transcript ( ε GT). This is essential for IgE production,Abbreviations: ε GT, ε germline transcript; IFN- γ, interferon-gamma; IgE, im- 
munoglobulin E; IL, interleukin; JAK, Janus kinase; OVA, ovalbumin; PGG, 1,2,3,4,6- 
penta- O -galloyl- β- d -glucose; STAT, signal transducer and activator of transcription; 
TGF- β, transforming growth factor-beta. 
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http://dx.doi.org/10.1016/j.fob.2013.07.008 through the tyrosine phosphorylation of signal transducers and acti-
vators of transcription (STAT) 6 molecule via the activation of Janus
kinases (JAK) [ 5 , 6 ]. IgE is associated with immediate hypersensitiv-
ity reactions that underlie atopic conditions such as urticaria and
eczema, seasonal allergy, food allergy, asthma, and anaphylaxis [ 7 ].
Therefore, inhibiting IgE production through blocking IL-4 signaling
may be effective in attenuating allergic disease. 
Although topical steroids, emollients and oral antihistamines are
used as ﬁrst-line therapy for allergy, many patients are still dissat-
isﬁed with present treatments and are worried about side effects.
Therefore, novel, safe pharmaceutical agents that inhibit IgE produc-
tion are required. If dietary intervention could inhibit the production
of IgE resulting from allergic responses, it may be a useful strategy for
therapy and prevention of allergy. 
Pentagalloylglucose (PGG) is a polyphenolic and water soluble gal-
lotannin isolated from various oriental herbs and plants such as gall-
nut of Rhus chinensis MILL. Botanically, PGG can exist in free form
or as a core structure of tannic acid, a higher galloylated glucose [ 8 ].
PGG has various biomedical properties such as anti-diabetic [ 9 , 10 ]
anti-oxidant [ 11 ], anti-cancer [ 12 , 13 ] and anti-inﬂammatory activi-
ties [ 14 , 15 ]. However, to our knowledge, no studies have reported that
PGG has an anti-allergic effect by inhibiting the IL-4 signaling path-
way, which is indispensable for class switching to IgE. Previously, we
showed that strictinin, an ellagitannin isolated from tea leaves, could
inhibit IgE production through the inhibition of IL-4-mediated sig-
naling in B cells [ 16 ]. Because of a structural similarity between PGG
and strictinin, the inhibitory effects of PGG on IL-4-induced allergicean Biochemical Societies. Open access under CC BY-NC-ND license.
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cesponses were analyzed. Furthermore, we also evaluated the effect 
f tannic acid, a higher galloylated PGG, on IgE production in mouse 
erum stimulated by ovalbumin. In this study, we found that PGG, a 
ore structure of tannic acid, has a speciﬁc inhibitory effect on the 
L-4 signaling pathway and that tannic acid has anti-IgE production 
ctivity. 
. Materials and methods 
.1. Chemicals 
Tannic acid extracted from Rhus javanica L ., Anacardiaceae, and 
GG were donated from Dr. Toshio Miyase, University of Shizuoka 
 17 ]. 
.2. Cells and cell culture 
The human Burkitt’s lymphoma cell line, DND39, in RPMI 1640 
edium and mouse embryonic ﬁbroblast cell line NIH3T3 cells in 
ulbecco’s modiﬁed Eagle’s medium (DMEM) (Cosmo Bio, Tokyo, 
apan) were maintained in media supplemented with 5% fetal bovine 
erum (FBS) (Intergen, Purchase, NY), 100 U / ml penicillin G, 100 μg / 
l streptomycin, and 10 mM HEPES buffer at 37 ◦C with 5% CO 2 . 
.3. Analysis of εGT expression 
DND39 cells (1 × 10 6 cells / ml) were stimulated with 250 U / 
l human recombinant IL-4 (hrIL-4) (R&D Systems Inc., Minneapo- 
is, USA) in RPMI 1640 medium containing 5% FBS. Total cellu- 
ar RNA was prepared using TRIzol reagent (Invitrogen Corp Carls- 
ad, CA, USA) according to the manufacturer’s recommended pro- 
ocol. Ten micrograms RNA of total RNA was reverse transcribed to 
DNA using 20 U of MMLV-reverse transcriptase (Amersham Phar- 
acia Biotech, Buckinghamshire, UK) and 0.5 μg of (dT) 20 primer 
n a reaction volume of 20 μl. When synthesizing cDNA for de- 
ection of ε GT, 1 μM of the ε GT-R, an anti-sense direction primer 
or ε GT, was used for reverse transcription. Reverse transcription- 
olymerase chain reaction (RT-PCR) was performed in a 10 μl reac- 
ion volume using 0.5 U of Amplitaq Gold DNA polymerase (Perkin- 
lmer Cetus, Norwalk, CT), 1 mM of each deoxynucleotide (Amer- 
ham Pharmacia Biotech), 1 μM of the appropriate primer for ε GT 
r GAPDH, and 0.5 or 0.05 μg of total RNA-equivalent cDNA. Speciﬁc 
robes for ε GT and GAPDH genes were made by labeling the fol- 
owing DNA: ε GT, 5 ′ -AGCTGTCCAGGAACCCCACAGGGAG-3 ′ ; GAPDH, 
CR-ampliﬁed GAPDH genes. Sample were predenatured at 95 ◦C for 
 min followed by ampliﬁcation at 95 ◦C for 30 s, 60 ◦C for 30 s, and 
2 ◦C for 30 s for 13 cycles ( ε GT) or 10 cycles (GAPDH), followed by a 
nal 7 min extension step at 72 ◦C. The ampliﬁed PCR products were 
ubjected to electrophoresis on a 1.5% agarose gel and transferred to 
 Hybond-N + membrane (Amersham Pharmacia Biotech) according 
o the manufacturer’s instructions. 
Primer sequences used in this experiment were as 
ollows: ε GT-F, 5 ′ -AGGCTCCACTGCCCGGCACAGAAAT-3 ′ ; 
 GT-R, 5 ′ -ACGGAGGTGGCATTGGAGGGAATGT-3 ′ ; GAPDH- 
, 5 ′ -GCTCAGACACCATGGGGAAGGT-3 ′ ; GAPDH-R, 5 ′ - 
TGGTGCAGGAGGCATTGCTGA-3 ′ . 
.4. Immunoprecipitation and western blotting 
hrIL-4-stimulated DND39 cells (2 × 10 6 cells / ml) were treated 
ith PGG or tannic acid in RPMI 1640 medium for 10 or 30 min. 
ells were lysed in lysis buffer containing 50 mM Tris–HCl (pH 7.6), 
50 mM NaCl, 1% (v / v) Triton X-100, 1 mM EDTA, 50 mM NaF, 30 mM 
a 4 P 2 O 7 , 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl 
uoride, and 2 μg / ml aprotinin. The cell extracts were immunopre- 
ipitated with the indicated antibodies followed by incubation with protein A-Sepharose beads (Amersham Bioscience). The washed im- 
munoprecipitates were separated using an 8% acrylamide gel, and 
transferred onto nitrocellulose membranes (Schleicher & Schuell Bio- 
Science, Inc., NH, USA). Membranes were then probed with speciﬁc 
antibodies. The bound antibody was detected using ECL (Amersham 
Pharmacia Biotech). Anti-STAT6 (S-20), anti-phosphotyrosine (PY20), 
anti-STAT1 p84 / p91 (E-23), anti-pSTAT1 (Tyr701), anti-human IL-4R α
(C-20) and anti-JAK3 (C-21) antibodies were purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA). Anti-phosphotyrosine antibody 
(4G10) was purchased from Upstate Biotechnology Inc. (Lake Placid, 
NY, USA). 
2.5. Animals 
Female 6-week-old C57BL / 6J mice were purchased from Charles 
River Laboratories Japan Inc. (Yokohama, Japan). The mice were kept 
at the Biotron Institute of Kyushu University in a 12-h light / 12-h dark 
cycle (lights on 8 a.m. to 8 p.m.) in an air-conditioned room (23–25 ◦C 
and 60% humidity under SPF conditions). This experiment was carried 
out according to the guidelines for animal experiments at the Faculty 
of Agriculture and the Graduate Course, Kyushu University, and the 
Law (No. 105) and Notiﬁcation (No. 6) of the Japanese government. 
The approval number of the animal experiment was A24-052-1. 
2.6. Immunization of mice with ovalbumin 
C57BL / 6J mice were divided into two groups of 5 mice each. Mice 
were administered water or water containing 4 mg / ml tannic acid for 
17 days ad libitum . Mice were primed with ovalbumin (OVA) (Grade 
IV, Sigma-Aldrich Chemical, St. Louis, MO) to induce speciﬁc IgE re- 
sponses as follows: 50 μg / ml OVA mixed with aluminum hydroxide 
(10 μg OVA / 1 mg aluminum; LSL Inc., Japan) were intraperitoneally 
injected on day 3. At 1 month after administration, concentrations of 
OVA-speciﬁc IgE, IgM, and IgG were measured in serum by enzyme- 
linked immunosorbent assay Quantitation Kit (Bethyl Laboratories, 
Montgomery, TX, USA). Speciﬁc IgE, IgM, and IgG antibodies were 
quantiﬁed using horseradish peroxidase-conjugated antibody. The 
relative band intensities were calculated by densitometric analysis 
using KyPlot software, ver. 4.0. 
2.7. Statistical analysis 
Data were analyzed using the unpaired t -test using Graphpad 
Prism 4.0 software (Graphpad Software Inc., San Diego, CA, USA). 
Mean values were statistically signiﬁcantly from the control group 
when p < 0.05. 
3. Results 
3.1. PGG inhibits IL-4-induced εGT expression 
The expression of ε GT is indispensable for IL-4-induced IgE class 
switching [ 18 ]. We ﬁrst examined the effect of PGG on ε GT expression 
in B cells induced by IL-4. Transforming growth factor (TGF)- β was 
used as a positive control for inhibiting IL-4-induced ε GT expression 
[ 19 ]. PGG inhibited IL-4-induced ε GT expression in a concentration- 
dependent manner ( Fig. 1 B). 
3.2. PGG suppressed IL-4-induced STAT6 activation by inhibiting IL-4 
signal pathway 
STAT6 is a critical transcription factor that selectively induces ε GT 
expression by IL-4 stimuli [ 20 ]. We evaluated the effect of PGG on the 
IL-4 induced signaling pathway. PGG inhibited IL-4-induced IL-4R α
phosphorylation and attenuated IL-4-induced JAK3 phosphorylation 
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Fig. 1. PGG inhibits IL-4-induced ε GT expression. (A) The structure of galloyl group, 
PGG, digallic acid and tannic acid. (B) DND39 cells were treated with PGG (1, 10, 25 μM) 
or TGF- β (2 ng / ml, positive control) in the presence of IL-4 (250 U / ml) for 48 h, and 
then assessed for the expression of ε GT by RT-PCR followed by Southern hybridization. 
Each experiment was repeated three times in triplicate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. PGG suppresses IL-4-induced STAT6 activation by inhibiting the IL-4 signal 
pathway. DND39 cells were stimulated with IL-4 (250 U / ml) in the presence of 25 
μM of PGG for 10 min or 30 min. Lysates were then immunoprecipitated with anti- 
JAK3, anti-IL-4R α, or anti-STAT6 antibodies and analyzed by western blotting using 
anti-phosphotyrosine antibody (4G10) for phosphorylated JAK3 and IL-4R α or anti- 
phosphotyrosine antibody (PY20) for phosphorylated STAT6. Each experiment was 
repeated three times in triplicate. 
Fig. 3. PGG speciﬁcally inhibits IL-4 and IL-13 signaling, but not IFN- γ signaling. (A) 
DND39 cells were treated with IFN- γ (400 ng / ml) and PGG for 30 min. Lysates were 
then immunoprecipitated with anti-STAT1 antibody and analyzed by western blotting 
using an anti-pTyr-STAT1 antibody. (B) NIH-3T3 cells were treated with IL-13 (10 
ng / ml) and PGG (50 μM) for 30 min. Lysates were then immunoprecipitated with 
anti-STAT6 antibody and analyzed by western blotting using an anti-phosphotyrosine 
antibody (PY20). Each experiment was repeated three times in triplicate. 
 
 
 
 
 
 ( Fig. 2 ). Furthermore, treatment of PGG for 30 min inhibited IL-4-
induced STAT6 phosphorylation ( Fig. 2 ). These results demonstrate
that PGG inhibited IL-4-induced ε GT expression and STAT6 phospho-
rylation by attenuating JAK3 and IL-4R α activation. 
3.3. PGG speciﬁcally inhibits IL-4 and IL-13 signaling, but not IFN- γ
signaling 
To explore whether the inhibitory effect of PGG is speciﬁc for
IL-4R α signaling, we investigated whether PGG inhibited other cy-
tokine signaling such as interferon (IFN)- γ, and IL-13. IFN- γ is a type
II cytokine and IL-13 is a type I cytokine whose receptor shares IL-
4R α, to which IL-4 binds [ 21 ]. PGG did not inhibit phosphorylation of
STAT1 ( Fig. 3 A). However, STAT6 phosphorylation induced by IL-13
was completely inhibited by PGG ( Fig. 3 B). These results suggest that
PGG might speciﬁcally inhibit IL-4 and IL-13 induced signaling. 
3.4. Tannic acid inhibits IgE production by suppressing IL-4-induced 
εGT expression and IL-4 signaling pathway 
In various oriental herbs and plants, PGG exists as tannic acid [ 8 ].
Therefore, we examined the effect of tannic acid on IL-4-induced ε GT
expression, IL-4R α, JAK3 and STAT6 activation in DND39 cells. Tan-
nic acid (1 μg / ml) inhibited IL-4-induced ε GT expression and sup-
pressed IL-4-stimulated STAT6 phosphorylation by inhibiting IL-4R α
and JAK3 activation by IL-4 treatment ( Fig. 4 ). To conﬁrm whether
tannic acid had an inhibitory effect on IgE production, we performed
in vivo experiments for antigen-speciﬁc IgE production. Mice were
administered water or water containing 4 mg / ml tannic acid ad libi-
tum for 17 days. We primed mice by intraperitoneal injection of OVA /aluminum hydroxide on day 3. At 1 month after tannic acid admin-
istration, a blood sample was taken from their tails and the levels of
total and OVA-speciﬁc IgE, IgM, and IgG were measured. The amounts
of total ( Fig. 5 A) or OVA-speciﬁc IgE ( Fig. 5 B) were reduced in the tan-
nic acid-administered mice compared with control mice. However,
total and OVA-speciﬁc levels of other Ig isotypes (IgM and IgG) were
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Fig. 4. Tannic acid inhibits IL-4-induced ε GT expression by suppressing the IL-4 sig- 
naling pathway. (A) DND39 cells were treated with tannic acid (1, 10 μg / ml) or TGF- β
(2 ng / ml) in the presence of IL-4 (250 U / ml) for 48 h, and then assessed for the ex- 
pression of ε GT by RT-PCR followed by Southern hybridization. (B) Cells were treated 
with tannic acid (1, 10 μg / ml) in the presence of IL-4 (250 U / ml) for 30 min. (C) Cells 
were stimulated with IL-4 (250 U / ml) in the presence of tannic acid (1, 10 μg / ml) 
for 10 min. Lysates were then immunoprecipitated with an anti-STAT6, anti-JAK3 and 
anti-IL-4R α antibodies and analyzed by western blotting using anti-phosphotyrosine 
antibody (4G10) for phosphorylated JAK3 and IL-4R αor anti-phosphotyrosine antibody 
(PY20) for phosphorylated STAT6. Each experiment was replicated three times with 
triplicate. 
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Fig. 5. Tannic acid inhibits antigen-speciﬁc IgE production in ovalbumin-treated mice. 
Female, 6-week-old C57BL / 6J mice were divided into two groups of 5 mice each. 
Mice were administered water or water containing 4 mg / ml tannic acid ad libitum 
for 17 days. Mice were intraperitoneally injected with 50 μg / ml OVA with aluminum 
hydroxide on day 3 to induce speciﬁc IgE responses. At 1 month after administration, 
the levels of total (A) and OVA-speciﬁc (B) IgE, IgM and IgG were measured in serum 
by ELISA. Statistical analysis was performed using unpaired t -test. Mean values were 
signiﬁcantly different from the control group: * p < 0.05 ( n = 5). n.s.: not signiﬁcant. ot signiﬁcantly affected ( Fig. 5 A and B). These results suggested that 
annic acid selectively suppressed antigen-speciﬁc IgE production in 
ivo by inhibiting ε GT expression and suppressing phosphorylation 
f STAT6 induced by IL-4. 
. Discussion 
PGG is a representative gallotannin and a core structure of tan- 
ic acid derived from oriental herbs. A number of studies demon- 
trated that PGG has a wide range of biological effects such as anti- 
iabetic, anti-oxidant, anti-cancer and anti-inﬂammatory activities 
 9 –15 ]. PGG especially exerts an anti-cancer effect by inhibiting the 
ctivation of JAK1 and STAT3 [ 12 ]. However, whether PGG possesses 
nti-allergic effects by inhibiting IL-4-induced signaling pathway is 
nclear. To our knowledge, this is the ﬁrst report to demonstrate that 
GG and tannic acid, higher galloylated PGGs, suppress IgE produc- 
ion by inhibiting IL-4 and IL-13-induced STAT6 phosphorylation and 
 GT expression. IL-4-induced STAT6 activation and ε GT expression are critical for 
the synthesis of IgE that is key in allergic disease [ 22 , 23 ]. In addi- 
tion to IL-4, IL-13 binds to IL-4R α, and therefore can induce similar 
responses generated by IL-4. The importance of IL-4 and IL-13 signal- 
ing was established in human asthma and animal models of asthma 
[ 24 –26 ], suggesting that both cytokine signaling pathways are targets 
for therapeutic intervention of allergic diseases. Thus, the inhibition 
of IL-4 and IL-13-induced signaling activation may be effective in at- 
tenuating allergic disease. In the current study, PGG inhibited IL-4- 
and IL-13-induced STAT6 tyrosine phosphorylation, but not the IFN- γ
signaling pathway. Because both IL-4 and IL-13 bind IL-4R α to acti- 
vate the same signaling pathway [ 21 ], IL-4R αmay be a target of PGG 
action. 
An explanation why PGG has a speciﬁc inhibitory effect on IL-4- 
induced signaling pathways might be its structural similarity with 
strictinin, an ellagitannin isolated from tea leaves that inhibits IgE 
production by suppressing the IL-4 signaling pathway [ 16 ]. PGG 
and strictinin are hydrolysable tannins that are esters of gallic acid 
with a polyol (typically β- d -glucose). Substitution of 1- O -galloyl- β- 
d -glucosepyranose, the most simple member of this group, leads to 
the fully galloylated glucose derivative, PGG. This can be subjected to 
oxidation reactions that form linkages between suitably orientated 
galloyl residues to yield hexahydroxydiphenoyl (HHDP) moieties, 
thus giving rise to a second subclass of hydrolysable tannins known 
as ellagitannins [ 27 ]. Interestingly, the deﬁning structural feature of 
hydrolysable tannins, including gallotannins (PGG) and ellagitannin 
(strictinin), is the inhibition of IgE production by inhibiting IL-4 and 
IL-13-induced signaling, although this needs to be explored further 
in future studies. 
In summary, our data show that PGG causes the strong suppres- 
sion of IL-4-induced ε GT expression, which is indispensable for IgE 
class switching and that the inhibition of ε GT expression may occur 
by attenuating activation of the IL-4 signaling pathway. Tannic acid, a 
higher galloyl glucose, also inhibits IgE production by suppressing IL- 
4-induced ε GT expression. In addition, the suppressive effect exerted 
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 by PGG is speciﬁc to IL-4 and IL-13 cytokines that inﬂuence the de-
velopment of allergic disease. These ﬁndings also highlight the ther-
apeutic potential of tannic acid and PGG as potential pharmaceutical
agents that may be useful to inhibit the progression of IgE-mediated
disease such as food allergy, seasonal allergy, and asthma. 
Acknowledgments 
This work was supported by Grants for project research (Devel-
opment of fundamental technology for analysis and evaluation of
functional agricultural products and functional foods), in part by JSPS
KAKENHI Grants Number 22228002, and Grant-in-Aid for JSPS Fel-
lows (25.2691). 
References 
[1] Ppulsen, L.K. and Hummelshoj, L. (2007) Triggers of IgE class switching and
allergy development. Ann Med 39, 440–456. 
[2] Mancini, A.J., Kaulback, K. and Chamlin, S.L. (2008) The socioeconomic impact
of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol
25(2), 1–6. 
[3] Ricci, M. (1994) IL-4: a key cytokine in atopy. Clin Exp Allergy 24, 801–812. 
[4] Pauwels, R.A., Brusselle, G.G., Tournoy, K.G., Lambrecht, B.N. and Kips, J.C. (1998)
Cytokines and their receptors as therapeutic targets in asthma. Clin Exp Allergy
28, 1–5. 
[5] Quelle, F.W., Shimoda, K. and Thierfelder, W. (1995) Cloning of murine Stat6 and
human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4
and IL-3 but are not required for mitogenesis. Mol Cell Biol 15, 3336–3343. 
[6] Schindler, U., Wu, P., Rothe, M. and McKnight, S.L. (1995) Components of a Stat
recognition code: evidence for two layers of molecular selectivity. Immunity 2,
689–697. 
[7] Corry, D.B. and Kheradmand, F. (1999) Induction and regulation of the IgE re-
sponse. Nature 402, B18–B23. 
[8] Li, L., Shaik, A.A., Zhang, J., Nhkata, K., Wang, L., Zhang, Y. et al. (2011) Preparation
of penta- O -galloyl- β- d -glucose from tannic acid and plasma pharmacokinetic
analyses by liquid-liquid extraction and reverse-phase HPLC. J Pharm Biomed
Anal 54, 545–550. 
[9] Liu, X., Kim, J.K., Li, Y., Li, J., Liu, F. and Chen, X. (2005) Tannic acid stimulates
glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr
135, 165–171. 
[10] Li, Y., Kim, J., Li, J., Liu, F., Liu, X., Himmeldirk, K. et al. (2005) Natural anti-
diabetic compound penta- O -galloyl- d -glucopyranose binds to insulin receptor
and activates insulin mediated glucose transport signaling pathway. Biochem
Biophys Res Commun 336, 430–437. 
[11] Lee, H.J., Jeong, S.J., Lee, H.J., Lee, E.O., Bae, H., Lieske, J.C. et al. (2011)1,2,3,4,6-Penta- O -galloyl-beta- d -glucose reduces renal crystallization and ox-
idative stress in a hyperoxaluric rat model. Kidney Int 79, 538–545. 
[12] Lee, H.J., Seo, N.J., Jeong, S.J., Park, Y., Jung, D.B., Koh, W. et al. (2011) Oral ad-
ministration of penta- O -galloyl-b- d -glucose suppresses triple-negative breast
cancer xenograft growth and metastasis in strong association with JAK1-STAT3
inhibition. Carcinogenesis 32, 804–811. 
[13] Yu, W.S., Jeong, S.J., Kim, J.H., Lee, H.J., Song, H.S., Kim, M.S. et al.
(2011) The genome-wide expression proﬁle of 1,2,3,4,6-penta- O -galloyl-b- d -
glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer
metabolism. Mol cells 32, 123–132. 
[14] Wu, M. and Gu, Z. (2009) Screening of bioactive compounds from moutan cortex
and their anti-inﬂammatory activities in rat synoviocytes. Evid Based Comple-
ment Altern Med 6, 57–63. 
[15] Lee, S.H., Park, H.H., Kim, J.E., Kim, J.A., Kim, Y.H., Jun, C.D. et al. (2007) Allose gal-
lates suppress expression of pro-inﬂammatory cytokines through attenuation
of NF-kappaB in human mast cells. Planta Med 73, 769–773. 
[16] Tachibana, H., Kuboa, T., Miyase, T., Taninoa, S., Yoshimoto, M., Sano, M. et al.
(2001) Identiﬁcation of an inhibitor for interleukin 4-induced germline tran-
scription and antigen-speciﬁc IgE production in vivo. Biochem Biophys Res
Commun 280, 53–60. 
[17] Kobayashi, W., Miyase, T., Sano, M., Umehara, K., Warashina, T. and Noguchi, H.
(2002) Prolyl endopeptidase inhibitors from the roots of Lindera strychnifolia F.
VILL Biol Pharm Bull 25, 1049–1052. 
[18] Gauchat, J.F., Lebman, D.A., Coffman, R.L., Gascan, H. and de Vries, J.E. (1990)
Structure and expression of germline epsilon transcripts in human B cells in-
duced by interleukin 4 to switch to IgE production. J Exp Med 172, 463–473. 
[19] Ichiki, T., Takahashi, W. and Watanabe, T. (1992) The effect of cytokines and
mitogens on the induction of C epsilon germline transcripts in a human Burkitt
lymphoma B cell line. Int Immunol 4, 747–754. 
[20] Yanagihara, Y., Ikizawa, K., Kajiwara, K., Koshio, T., Basaki, Y. and Akiyama, K.
(1995) Functional signiﬁcance of IL-4 receptor on B cells in IL-4-induced human
IgE production. J Allergy Clin Immunol 96, 1145–1151. 
[21] Leonard, W.J. and O ’ Shea, J.J. (1998) Jaks and STATs: biological implications.
Annu Rev Immunol 16, 293–322. 
[22] Holgate, S.T. (1999) The epidemic of allergy and asthma. Nature 402, B2–B4. 
[23] Nelms, K., Keegan, A.D., Zamorano, J., Ryan, J.J. and Paul, W.E. (1999) The IL-4
receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17,
701–738. 
[24] Mueller, T.D., Zhang, J.L., Sebald, W. and Duschl, A. (2002) Structure, binding,
and antagonistst in the IL-4 / IL-13 receptor system. Biochim Biophys Acta 1592,
237–250. 
[25] Izuhara, K. (2003) The role of interleukin-4 and interleukin-13 in the non-
immunologic aspects of asthma pathogenesis. Clin Chem Lab Med 41, 860–864. 
[26] Hahn, C., Teufel, M., Herz, U., Renz, H., Erb, K.J., Wohlleben, G. et al. (2003) Inhi-
bition of the IL-4 / IL-13 receptor system prevents allergic sensitization without
affecting established allergy in a mouse model for allergic asthma. J Allergy Clin
Immunol 111, 1361–1369. 
[27] Niemetz, R. and Gross, G.G. (2005) Enzymology of gallotannin and ellagitannin
biosynthesis. Phytochemistry 66, 2001–2011. 
